Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SRPT | TECH | EXEL | ||
Company | Sarepta Therapeutics | Bio-Techne Corp | Exelixis Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 108.54 | 72.27 | 34.98 | ||
High | 108.70 | 72.46 | 35.13 | ||
Low | 102.57 | 67.48 | 34.06 | ||
Last | 104.54 | 67.57 | 34.45 | ||
Change | -4.57 | -4.97 | -0.60 | ||
% Change | -4.19% | -6.85% | -1.71% | ||
Volume | 1,571,000 | 2,449,200 | 2,867,700 | ||
20-Day Average Volume | 1,023,375 | 1,072,500 | 2,560,570 | ||
Previous Close | 109.11 | 72.54 | 35.05 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 123.13 | 72.99 | 32.61 | ||
20-Day Raw Stochastic | 6.40% | 0.68% | 75.40% | ||
20-Day Relative Strength | 28.25% | 39.38% | 68.62% | ||
Weighted Alpha | -6.41 | +0.34 | +73.03 | ||
Today's Opinion | 88% Sell | 64% Sell | 100% Buy | ||
Previous Opinion | 72% Sell | 56% Sell | 100% Buy | ||
Last Month's Opinion | 72% Sell | 8% Sell | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -14.04% since 11/08/24 | -11.05% since 11/08/24 | -4.97% since 11/08/24 | ||
Low | 102.57 on 11/15/24 | 67.48 on 11/15/24 | 34.06 on 11/15/24 | ||
High | 122.63 on 11/11/24 | 76.49 on 11/11/24 | 36.49 on 11/12/24 | ||
1-Month | |||||
%Chg | -15.51% since 10/15/24 | -8.18% since 10/15/24 | +20.88% since 10/15/24 | ||
Low | 102.57 on 11/15/24 | 67.48 on 11/15/24 | 27.86 on 10/25/24 | ||
High | 133.36 on 10/25/24 | 80.80 on 11/06/24 | 36.60 on 11/08/24 | ||
3-Month | |||||
%Chg | -21.60% since 08/15/24 | -9.80% since 08/15/24 | +30.94% since 08/15/24 | ||
Low | 102.57 on 11/15/24 | 67.48 on 11/15/24 | 25.12 on 09/09/24 | ||
High | 144.22 on 08/22/24 | 80.95 on 09/19/24 | 36.60 on 11/08/24 | ||
6-Month | |||||
%Chg | -21.10% since 05/15/24 | -19.08% since 05/15/24 | +63.12% since 05/15/24 | ||
Low | 102.57 on 11/15/24 | 67.48 on 11/15/24 | 20.14 on 05/29/24 | ||
High | 173.25 on 06/21/24 | 84.61 on 05/17/24 | 36.60 on 11/08/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 9,985,660 | 10,736,331 | 9,838,197 | ||
Shares Outstanding, K | 95,520 | 158,892 | 285,579 | ||
Annual Sales | 1,243,340,000 | 1,159,060,000 | 1,830,210,000 | ||
Annual Net Income | -535,980,000 | 168,110,000 | 207,770,000 | ||
Last Quarter Sales | 467,170,000 | 289,460,000 | 539,540,000 | ||
Last Quarter Net Income | 33,610,000 | 33,600,000 | 117,970,000 | ||
60-Month Beta | 0.81 | 1.28 | 0.51 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.62 on 11/06/24 | 0.42 on 10/30/24 | 0.47 on 10/29/24 | ||
Latest Earnings Date | 11/06/24 | 10/30/24 | 10/29/24 | ||
Most Recent Dividend | N/A | 0.080 on 11/08/24 | N/A | ||
Next Ex-Dividends Date | N/A | 11/08/24 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 94.06 | 44.50 | 22.76 |